{
    "2021-11-17": [
        [
            {
                "time": "",
                "original_text": "伏罗尼布（CM082）缓释制剂EYP-1901治疗w-AMD发布I期临床试验中期数据",
                "features": {
                    "keywords": [
                        "伏罗尼布",
                        "CM082",
                        "缓释制剂",
                        "EYP-1901",
                        "w-AMD",
                        "I期临床试验",
                        "中期数据"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国内市场15个小分子靶向肺癌药，原研与仿制谁将取胜？",
                "features": {
                    "keywords": [
                        "小分子靶向药",
                        "肺癌",
                        "原研药",
                        "仿制药",
                        "市场竞争"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}